Relationship between bilirubin and C-reactive protein

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 11, 2011, Pages 1823-1828

  Hwang, Hee Jin ^a   Lee, Sang Woo ^a   Kim, Sang Hwan ^a  

^a Kwandong University College of Medicine   (South Korea)

Author keywords

Bilirubin; C reactive protein; Inflammation

Indexed keywords

BILIRUBIN; BILIRUBIN GLUCURONIDE; C REACTIVE PROTEIN;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY MASS; CARDIOVASCULAR RISK; FEMALE; HUMAN; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL;

EID: 80755187935     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.662     Document Type: Article

References (33)

1. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998;97:596-601. (Pubitemid 28090690)
2. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: global Burden of Disease Study. Lancet 1997;349: 1269-76. (Pubitemid 27192468)
3. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analysis. Br Med J 2000; 321:199-204. (Pubitemid 30459555)
4. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9. (Pubitemid 27152782)
5. Tracy R. Inflammation in cardiovascular disease: cart, horse or both? Circulation 1998;97:2000-2.
6. Vigushin DM, Pepys MB, Hawkin PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993;91:1351-7. (Pubitemid 23127332)
7. Albert MA. The role of C-reactive protein in cardiovascular disease risk. Curr Cardiol Rep 2000;2:274-9.
8. de Ferranti S, Rifai N. C-reactive protein and cardiovascular disease: a review of risk prediction and interventions. Clin Chim Acta 2002;317:1-15. (Pubitemid 34114013)
9. Jialal I, Devaraj S. Inflammatio and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker. Am J Clin Pathol 2001;116:108-15.
10. Ridker PM, Hennekens CH, Buring JE, Rafai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342: 836-43. (Pubitemid 30165206)
11. Steven DL. Jaundice. In: Feldman M, editor. Sleisenger and Fordtran's gastrointestinal and liver disease, 8th ed. Philadelphia, PA: Saunders, 2006:301-14.
12. Baranano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 2002;99:16093-8. (Pubitemid 35462754)
13. Bulmer AC, Blanchfield JT, Toth I, Fassett RG, Coombes JS. Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection. Atherosclerosis 2008;199:390-6.
14. Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 1994;40:18-23. (Pubitemid 24050206)
15. Hopkins PN, Wu LL, Hunt SC, James BC, Vincent GM, Williams RR. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 1996;16:250-5. (Pubitemid 26056243)
16. Djousse L, Levy D, Cupples LA, Evans JC, D'Agostino RB, Ellison RC. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 2001;87:1196-200. (Pubitemid 32453243)
17. Temme EH, Zhang J, Schouten EG, Kesteloot H. Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Contr 2001;12:887-94. (Pubitemid 34048869)
18. Troughton JA, Woodside JV, Young IS, Arveiler D, Amouyel P, Ferrières J, et al. Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Eur J Cardiovasc Prev Rehabil 2007;14:79-84.
19. Ko GT, Chan JC, Woo J, Lau E, Yeung VT, Chow CC, et al. Serum bilirubin and cardiovascular risk factors in a Chinese population. J Cardiovasc Risk 1996;3:459-63. (Pubitemid 27051345)
20. Madhavan M, Wattingney WA, Srinivasan SR, Berenson GS. Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults. Atherosclerosis 1997;131: 107-13. (Pubitemid 27240103)
21. Lin LY, Kuo HK, Hwang JJ, Lai LP, Chiang FT, Tseng CD, et al. Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents. Atherosclerosis 2009;203:563-8.
22. Chin HJ, Song YR, Kim HS, Park MS, Yoon HJ, Na KY, et al. The bilirubin level is negatively correlated with the incidence of hypertension in normotensive Korean population. J Korean Med Sci 2009;24:S50-6.
23. Mazzone GL, Rigato I, Ostrow JD, Bossi F, Bortoluzzi A, Sukowati CH, et al. Bilirubin inhibits the TNFa-related induction of three endothelial adhesion molecules. Biochem Biophys Res Commun 2009;386;338-44.
24. Öllinger R, Yamashita K, Bilban M, Erat A, Kogler P, Thomas M, et al. Bilirubin and biliverdin treatment of atherosclerotic diseases. Cell Cycle 2007;6:39-43. (Pubitemid 46173878)
25. Öllinger R, Bilban M, Erat A, Froio A, McDaid J, Tyagi S, et al. Bilirubin a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 2005;112:1030-9. (Pubitemid 41170272)
26. Novotny L, Vitek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood) 2003;228:568-71. (Pubitemid 37203679)
27. Tanakaa M, Fukui M, Tomiyasuc K-I, Akabamec S, Nakanoc K, Hasegawaa G, et al. Low serum bilirubin concentration is associated with coronary artery calcification (CAC). Atherosclerosis 2009;206:287-91.
28. Wolkoff AW. The hyperbilirubinemias: Harrison's principles of internal medicine. 16th ed. New York, NY: McGraw-Hill, 2005: 1817-21.
29. Nakagami T, Toyomura K, Kinoshita T, Morisawa S. A beneficial role of bile pigments as an endogenous tissue protector: anticomplement effects of biliverdin and conjugated bilirubin. Biochim Biophys Acta 1993;1158:189-93. (Pubitemid 23291461)
30. Ghem C, Sarmento-Leite RE, de Quadros AS, Rossetto S, Gottschall CA. Serum blirubin concentration in patients with an established coronary artery disease. Int Heart J 2010;51: 86-91.
31. Perlstein TS, Pande RL, Beckman JA, Creager MA. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: national Health and Nutrition Examination Survey (NHANES) 1999-2004. Arterioscler Thromb Vasc Biol 2008; 28:166-72.
32. Franchini M, Targher G, Lippi G. Serum bilirubin levels and cardiovascular disease risk: A Janus Bifrons? Adv Clin Chem 2010;50:47-63
33. Lippi G, Targher G, Montagnana M, Salvagno GL, Guidi GC. Bilirubin concentration and cardiovascular risk profile. Liver Int 2009;29:315-6.